# IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs

> **NCT00128518** · PHASE4 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 139 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Indapamide (T2)
- **DRUG:** Perindopril (T1)
- **DRUG:** Placebo of Perindopril (P1)
- **DRUG:** Placebo of Indapamide (P2)

## Key facts

- **NCT ID:** NCT00128518
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128518, "IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00128518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*